M&A Deal Summary

Torrent Pharmaceuticals Acquires JBCPL

On June 29, 2025, Torrent Pharmaceuticals acquired life science company JBCPL from KKR

Acquisition Highlights
  • This is Torrent Pharmaceuticals’ 4th transaction in the Life Science sector.
  • This is Torrent Pharmaceuticals’ 4th transaction in India.

M&A Deal Summary

Date 2025-06-29
Target JBCPL
Sector Life Science
Buyer(s) Torrent Pharmaceuticals
Sellers(s) KKR
Deal Type Add-on Acquisition
Advisor(s) Goldman Sachs (Financial)
Shardul Amarchand Mangaldas & Co. (Legal)

Target

JBCPL

Mumbai, India
JBCPL is a formulation pharma company in India with a domestic brand portfolio and exports to several international markets. JBCPL was formed in 1976 and is based in Mumbai, India.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Torrent Pharmaceuticals

Ahmedabad, India

Category Company
Sector Medical Products
Employees17,059
Revenue 113.2B INR (2025)
DESCRIPTION

Torrent Pharmaceuticals is a manufacturer and seller of branded and unbranded generic pharmaceutical products. Torrent Pharmaceuticals is based in Ahmedabad, Gujarat.


DEAL STATS #
Overall 5 of 5
Sector: Life Science M&A 4 of 4
Type: Add-on Acquisition M&A Deals 3 of 3
Country: India M&A 4 of 4
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-27 Curatio Healthcare

Chennai, India

Curatio Healthcare is a pharmaceutical company that is focused on the dermatology and pediatric segments, which are among the most attractive therapy areas within the pharmaceutical industry. Curatio Healthcare was founded in 2005 and is based in Chennai, India.

Buy Rs20.0B

Seller(S) 1

SELLER

KKR

New York, New York, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1976
PE ASSETS 267.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION
KKR's office in Menlo Park, California.
KKR's office in Menlo Park, California.

KKR is a global investment firm founded by Jerome Kohlberg, Henry Kravis, and George Roberts. The Firm is separated into several business segments including private markets, public markets, capital markets, and other principal activities. KKR's private equity practice invests in management buyouts, take privates, corporate divestitures, industry consolidations, and partnerships with family-owned companies. KKR will invest in a broad range of industries and companies and will consider businesses throughout North America, Europe, Asia, and Australia/New Zealand. Sectors of interest include chemicals, consumer products, energy and natural resources, financial services, healthcare, industrial, media/communications, retail, and technology. In addition to its traditional principal investment activity business, KKR also invests in infrastructure assets. KKR was formed in 1976 and is based in New York, New York.


DEAL STATS #
Overall 211 of 215
Sector: Life Science M&A 9 of 10
Type: Add-on Acquisition M&A Deals 69 of 69
Country: India M&A 8 of 8
Year: 2025 M&A 1 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-06-16 Zenith Energy

Rivervale, Australia

Zenith specializes in the delivery of sustainable and reliable hybrid power solutions for remote, off-grid resource sector clients and urban microgrids for commercial, industrial, and residential precincts. Zenith Energy is based in Rivervale, Australia.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-07-02 Spectris

London, United Kingdom

Spectris is a supplier of productivity enhancing instrumentation and controls. The Company's products and technologies help customers to improve product quality and performance, improve core manufacturing processes, reduce downtime and wastage and reduce time to market. Spectris operates across four business segments which reflect the applications and industries it serves: Materials Analysis, Test and Measurement, In-line Instrumentation and Industrial Controls. Spectris was founded in 1915 and is based in London, United Kingdom.

Buy £4.7B